Related Experiment Video
Updated: Jul 10, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease
Nigel D Toussaint1, Kenneth K Lau, Boyd J Strauss
1Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia. Nigel.Toussaint@med.monash.edu.au
Insights
Vascular calcification (VC) is highly prevalent in pre-dialysis chronic kidney disease (CKD) patients, worsening with age and reduced kidney function. Measuring VC and arterial stiffness may aid cardiovascular risk assessment in CKD.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Vascular calcification (VC) and arterial stiffness are significant contributors to cardiovascular disease (CVD) in chronic kidney disease (CKD).
- Both VC and arterial stiffness are independent predictors of cardiovascular mortality.
- Few studies have investigated VC prevalence in pre-dialysis CKD patients, alongside bone mineral density (BMD) and arterial compliance.
Purpose of the Study:
- To assess the prevalence of vascular calcification (VC) in pre-dialysis chronic kidney disease (CKD) patients.
- To investigate the associations between VC, arterial stiffness, bone mineral density (BMD), and clinical parameters.
- To evaluate the utility of VC and arterial stiffness measurements for cardiovascular risk assessment in CKD.
Main Methods:
- Cross-sectional study of 48 pre-dialysis CKD patients (GFR 17-55 ml/min).
- Computed tomography (CT) scans for abdominal aorta and superficial femoral artery (SFA) VC assessment.
- Pulse wave velocity (PWV) for arterial stiffness, dual-energy X-ray absorptiometry (DEXA) for BMD, and serum markers for renal function and mineral metabolism were measured.
Main Results:
- 90% of patients exhibited some aortic VC; VC correlated positively with age, triglycerides, and PWV, and inversely with renal function.
- Multivariate analysis showed age and triglycerides were significantly associated with aortic VC and PWV.
- Superficial femoral artery (SFA) VC was inversely correlated with femoral BMD (T-scores), while vertebral BMD measurements were unreliable in this cohort.
Conclusions:
- High prevalence of VC in pre-dialysis CKD, associated with aging, triglycerides, and declining renal function.
- VC and arterial stiffness (PWV) may be valuable for cardiovascular risk stratification in CKD patients.
- Femoral BMD is inversely related to SFA VC; vertebral BMD assessment via DEXA is unreliable in CKD patients with VC.
Background:
Vascular calcification (VC) and arterial stiffness are major contributors to cardiovascular (CV) disease in chronic kidney disease (CKD). Both are independent predictors of CV mortality and are inversely correlated with bone mineral density (BMD). Few studies have addressed the extent of VC in the pre-dialysis CKD population, with associated measurements of BMD and arterial compliance.
Methods:
We report cross-sectional data on 48 patients with CKD (GFR 17-55 ml/min) assessing the prevalence of VC and its associations. All patients had computed tomography (CT) scans through abdominal aorta and superficial femoral arteries (SFAs) to determine VC, pulse wave velocity (PWV) using SphygmoCor device (AtCor PWV Inc., Westmead, Australia) measuring arterial stiffness, and dual-energy X-ray absorptiometry (DEXA) scans to determine BMD, as well as serum markers of renal function and mineral metabolism.
Results:
Patients, 71% male, 54% diabetic, had a median age 64.5 years. Mean estimated GFR was 35.1 +/- 10 ml/min. Mean PWV was 10.0 +/- 4.5 m/s and mean aortic VC score was 421.5 +/- 244 Hounsfield units, with 90% of subjects having some aortic VC present. In univariate linear regression analysis, aortic VC correlated positively with age (r 0.50, P < 0.001), triglycerides (r 0.47, P = 0.002) and PWV (r 0.33, P = 0.03). There was also greater VC with declining renal function (r -0.28, P = 0.05). There was no significant association between VC and serum markers of mineral metabolism, however phosphate and Ca x P correlated positively with PWV (r 0.35, P = 0.02, r 0.36, P = 0.02, respectively). There was also a positive association between PWV and triglycerides (P = 0.008), and a trend towards greater PWV with increasing age (P = 0.09). In multivariate regression analysis only increasing age and triglyceride levels were significantly associated with aortic VC and PWV. Mean spine and femoral T-scores on DEXA were 0.48 and -1.31 respectively, with 13% of subjects having femoral T-score <-2.5 (osteoporotic range). SFA VC inversely correlated with femoral T-scores (r -0.43, P = 0.004); however, there was a positive (likely false) association between spine T-scores and aortic VC (r 0.37, P = 0.01), related to the limitation of vertebral DEXA in CKD.
Conclusion:
There is a high prevalence of VC in pre-dialysis CKD patients, worse with increasing age, triglycerides and reducing renal function. Correlation exists between VC and PWV and determination of one or both may be useful for CKD patient CV risk assessment. Femoral BMD is inversely associated with SFA VC, but measurement of vertebral BMD by DEXA is unreliable in CKD patients with aortic VC.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

